COFACE, COFACE, Another 7 Companies Have A High Estimated Dividend Yield

(VIANEWS) – COFACE (COFA.PA), COFACE (COFA.PA), COVIVIO (COV.PA) have the highest dividend yield stocks on this list.

Financial Asset Forward Dividend Yield Updated (EST)
COFACE (COFA.PA) 13.22% 2023-12-21 09:01:20
COFACE (COFA.PA) 13.22% 2023-12-21 09:01:20
COVIVIO (COV.PA) 7.78% 2023-12-21 09:01:29
COVIVIO HOTELS (COVH.PA) 7.69% 2023-12-21 09:01:31
FERM.CAS.MUN.CANNE (FCMC.PA) 4.43% 2023-12-17 07:46:18
SANOFI (SAN.PA) 4.06% 2023-12-21 09:22:16
UNILEVER (UNA.AS) 3.9% 2023-12-21 08:04:13
TRIGANO (TRI.PA) 2.81% 2023-12-21 09:24:03
CAMBODGE NOM. (CBDG.PA) 2.75% 2023-12-18 09:00:46

Several Euronext companies pay out dividends to its shareholders. The dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. COFACE (COFA.PA)

13.22% Foward Dividend Yield

COFACE’s last close was €11.81, 18.21% below its 52-week high of €14.44. Intraday change was -0.17%.

COFACE SA, through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners. The company offers credit insurance products to protect companies against default on payment of its trade receivables. It also provides integrated credit management solutions comprising credit insurance, single risk insurance, business information and debt collection services for insured and uninsured businesses; and factoring services, as well as contract and environmental surety, customs and excise, and legal bonds; and payment guarantees. In addition, the company offers business information services through its ICON portal, an information services web platform. It operates in Western Europe, Northern Europe, Central and Eastern Europe, the Mediterranean and Africa, North America, Latin America, and the Asia-Pacific. COFACE SA was founded in 1946 and is headquartered in Bois-Colombes, France.

Earnings Per Share

As for profitability, COFACE has a trailing twelve months EPS of €1.92.

PE Ratio

COFACE has a trailing twelve months price to earnings ratio of 6.1. Meaning, the purchaser of the share is investing €6.1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.56%.

Earnings Before Interest, Taxes, Depreciation, and Amortization

COFACE’s EBITDA is 2.29.

More news about COFACE.

2. COFACE (COFA.PA)

13.22% Foward Dividend Yield

COFACE’s last close was €11.81, 18.21% under its 52-week high of €14.44. Intraday change was -0.17%.

COFACE SA, through its subsidiaries, provides credit insurance products and related services for microenterprises, small and medium enterprises, mid-market companies, international corporations, financial institutions, and clients of distribution partners. The company offers credit insurance products to protect companies against default on payment of its trade receivables. It also provides integrated credit management solutions comprising credit insurance, single risk insurance, business information and debt collection services for insured and uninsured businesses; and factoring services, as well as contract and environmental surety, customs and excise, and legal bonds; and payment guarantees. In addition, the company offers business information services through its ICON portal, an information services web platform. It operates in Western Europe, Northern Europe, Central and Eastern Europe, the Mediterranean and Africa, North America, Latin America, and the Asia-Pacific. COFACE SA was founded in 1946 and is headquartered in Bois-Colombes, France.

Earnings Per Share

As for profitability, COFACE has a trailing twelve months EPS of €1.92.

PE Ratio

COFACE has a trailing twelve months price to earnings ratio of 6.1. Meaning, the purchaser of the share is investing €6.1 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 14.56%.

More news about COFACE.

3. COVIVIO (COV.PA)

7.78% Foward Dividend Yield

COVIVIO’s last close was €48.50, 27.18% below its 52-week high of €66.60. Intraday change was -1.06%.

Thanks to its partnering history, its real estate expertise and its European culture, Covivio is inventing today's user experience and designing tomorrow's city. A preferred real estate player at the European level, Covivio is close to its end users, capturing their aspirations, combining work, travel, living, and co-inventing vibrant spaces. A benchmark in the European real estate market with €24,8 bn in assets, Covivio offers support to companies, hotel brands and territories in their pursuit for attractiveness, transformation and responsible performance. Build sustainable relationships and well-being, is the Covivio's Purpose who expresses its role as a responsible real estate operator to all its stakeholders: customers, shareholders and financial partners, internal teams, local authorities but also to future generations and the planet. Furthermore, its living, dynamic approach opens up exciting project and career prospects for its teams. Covivio's shares are listed in the Euronext Paris A compartment (FR0000064578 – COV), are admitted to trading on the SRD, and are included in the composition of the MSCI, SBF 120, Euronext IEIF "SIIC France" and CAC Mid100 indices, in the "EPRA" and "GPR 250" benchmark European real estate indices, and in the ESG FTSE4 Good, CAC SBT 1.5°C, DJSI World & Europe, Euronext Vigeo (World 120, Eurozone 120, Europe 120 and France 20), Euronext CDP Environment France EW, ISS ESG, Ethibel and Gaïa ethical indices and also holds the following awards and ratings: CDP (B), GRESB (90/100, 5-Star, 100% public disclosure), Vigeo-Eiris (A1+), ISSESG (B-) and MSCI (AAA).

Earnings Per Share

As for profitability, COVIVIO has a trailing twelve months EPS of €-9.11.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is negative -7.46%.

Volatility

COVIVIO’s last week, last month’s, and last quarter’s current intraday variation average was 0.16%, 0.50%, and 1.65%.

COVIVIO’s highest amplitude of average volatility was 0.78% (last week), 1.44% (last month), and 1.65% (last quarter).

Volume

Today’s last reported volume for COVIVIO is 18470 which is 87.25% below its average volume of 144867.

Dividend Yield

As stated by Morningstar, Inc., the next dividend payment is on Apr 24, 2023, the estimated forward annual dividend rate is 3.75 and the estimated forward annual dividend yield is 7.78%.

More news about COVIVIO.

4. COVIVIO HOTELS (COVH.PA)

7.69% Foward Dividend Yield

COVIVIO HOTELS’s last close was €16.35, 10.66% below its 52-week high of €18.30. Intraday change was 0%.

Covivio Hotels specializes in owning business premises in the hotel sector. A listed real estate investment company (SIIC), a real estate partner of the major players in the hotel industry, Covivio Hotels holds assets worth EUR 6.6 billion (at end 2022). Covivio Hotels is graded BBB+ / Stable outlook by Standard and Poor's.

Earnings Per Share

As for profitability, COVIVIO HOTELS has a trailing twelve months EPS of €3.23.

PE Ratio

COVIVIO HOTELS has a trailing twelve months price to earnings ratio of 5.06. Meaning, the purchaser of the share is investing €5.06 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 5.55%.

Yearly Top and Bottom Value

COVIVIO HOTELS’s stock is valued at €16.35 at 11:50 EST, way under its 52-week high of €18.30 and way above its 52-week low of €14.50.

Volume

Today’s last reported volume for COVIVIO HOTELS is 267 which is 83.74% below its average volume of 1643.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, COVIVIO HOTELS’s stock is considered to be overbought (>=80).

More news about COVIVIO HOTELS.

5. FERM.CAS.MUN.CANNE (FCMC.PA)

4.43% Foward Dividend Yield

FERM.CAS.MUN.CANNE’s last close was €1,680.00, 7.18% below its 52-week high of €1,810.00. Intraday change was 0%.

Société Fermière du Casino Municipal de Cannes operates casinos and hotels in France. The company operates 3 hotels with 565 rooms, suites, and cottages under the Hôtel Barrière Le Majestic, the Hôtel Barrière Le Gray d'Albion, and the Hôtel Barrière Le Carl Gustaf St-Barth brands; and 2 casinos, including 350 slot machines and 38 games tables under the Casino Barrière Croisette and Casino Barrière Les Princes brands. It also operates 8 restaurants, 9 bars, and 1 spa. The company was founded in 1919 and is based in Cannes, France.

Earnings Per Share

As for profitability, FERM.CAS.MUN.CANNE has a trailing twelve months EPS of €78.96.

PE Ratio

FERM.CAS.MUN.CANNE has a trailing twelve months price to earnings ratio of 21.28. Meaning, the purchaser of the share is investing €21.28 for every euro of annual earnings.

Moving Average

FERM.CAS.MUN.CANNE’s worth is below its 50-day moving average of €1,711.80 and above its 200-day moving average of €1,663.85.

Yearly Top and Bottom Value

FERM.CAS.MUN.CANNE’s stock is valued at €1,680.00 at 11:50 EST, below its 52-week high of €1,810.00 and way above its 52-week low of €1,280.00.

More news about FERM.CAS.MUN.CANNE.

6. SANOFI (SAN.PA)

4.06% Foward Dividend Yield

SANOFI’s last close was €88.96, 15.42% below its 52-week high of €105.18. Intraday change was -0.3%.

Sanofi, a healthcare company, engages in the research, development, manufacture, and marketing of therapeutic solutions in the United States, Europe, and internationally. It operates through Pharmaceuticals, Vaccines, and Consumer Healthcare segments. The company provides specialty care, such as dupixent, neurology and immunology, rare diseases, oncology, and rare blood disorders; medicines for diabetes and cardiovascular diseases; and established prescription products. In addition, it offers poliomyelitis, pertussis, and hib pediatric vaccines; influenza, booster, meningitis, and travel and endemic vaccines, which includes hepatitis A, typhoid, cholera, yellow fever, and rabies vaccines. The company also provides cough, cold, and flu, allergy, and pain care products, as well as physical, mental, and digestive wellness products; and offers body lotions, anti-itch products, moisturizing and soothing lotions, body and foot creams, and eczema powders. Further, it has a collaboration and license agreement with Exscientia to develop up to 15 novel small-molecule for oncology and immunology; ABL Bio, Inc. to develop ABL301 for Parkinson's disease; Blackstone Life Sciences to develop pivotal studies and clinical development program; and Seagen Inc. to design, develop, and commercialize antibody-drug conjugates for cancer. Additionally, the company has a collaboration agreement with IGM Biosciences, Inc. to develop, manufacture, and commercialize IgM antibody; Skyhawk Therapeutics, Inc to discover and develop novel small molecules; and Amunix Pharmaceuticals, Inc for T-cell engagers and cytokine therapies. It also enters in a strategic collaboration with Scribe Therapeutics Inc. to develop genome editing technologies; and co-promotion service agreement with Provention Bio, Inc. for the commercialization of teplizumab. The company was formerly known as Sanofi-Aventis and changed its name to Sanofi in May 2011. Sanofi was founded in 1973 and is headquartered in Paris, France.

Earnings Per Share

As for profitability, SANOFI has a trailing twelve months EPS of €7.22.

PE Ratio

SANOFI has a trailing twelve months price to earnings ratio of 12.31. Meaning, the purchaser of the share is investing €12.31 for every euro of annual earnings.

Volume

Today’s last reported volume for SANOFI is 356042 which is 79.3% below its average volume of 1720430.

More news about SANOFI.

7. UNILEVER (UNA.AS)

3.9% Foward Dividend Yield

UNILEVER’s last close was €43.81, 13.98% below its 52-week high of €50.93. Intraday change was -0.3%.

Unilever PLC operates as a fast-moving consumer goods company. It operates through Beauty & Wellbeing, Personal Care, Home Care, Nutrition, and Ice Cream segments. The Beauty & Wellbeing segment engages in the sale of hair care products, such as shampoo, conditioner, and styling; skin care products including face, hand, and body moisturizer; and prestige beauty and health & wellbeing products, which includes the vitamins, minerals, and supplements. Personal Care segment offers skin cleansing products comprising soap and shower, deodorant and oral care products, such as toothpaste, toothbrush, and mouthwash products. Home Care segment engages in the sale of fabric care including washing powders and liquids, and rinse conditioners; and home and hygiene, fabric enhancers, water and air wellness products. Nutrition segment provides the sale of scratch cooking aids, which includes soups, bouillons, and seasonings; dressings products, such as mayonnaise and ketchup; and beverages and functional nutrition products including Horlicks and Boost, as well as tea products. Ice Cream segment offers ice cream products including in-home and out-of-home ice creams. It offers its products under the AXE, Bango, Ben & Jerry's, Cif, Comfort, Domestos, Dove, Equilibra, Hellmann's, Knorr, LUX, Lifebuoy, Liquid I.V., Love Beauty & Planet, Magnum, OLLY, OMO, Onnit, Rexona, Seventh Generation, SmartPants, Sunsilk, The Vegetarian Butcher, Vaseline, and Wall's brands. The company was founded in 1860 and is headquartered in London, the United Kingdom.

Earnings Per Share

As for profitability, UNILEVER has a trailing twelve months EPS of €3.26.

PE Ratio

UNILEVER has a trailing twelve months price to earnings ratio of 13.4. Meaning, the purchaser of the share is investing €13.4 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 39.9%.

Moving Average

UNILEVER’s worth is under its 50-day moving average of €44.62 and below its 200-day moving average of €46.92.

Stock Price Classification

According to the stochastic oscillator, a useful indicator of overbought and oversold conditions, UNILEVER’s stock is considered to be oversold (<=20).

Dividend Yield

As maintained by Morningstar, Inc., the next dividend payment is on Nov 16, 2023, the estimated forward annual dividend rate is 1.71 and the estimated forward annual dividend yield is 3.9%.

More news about UNILEVER.

8. TRIGANO (TRI.PA)

2.81% Foward Dividend Yield

TRIGANO’s last close was €147.00, 4.4% above its 52-week high of €140.80. Intraday change was -1.56%.

Trigano S.A., together with its subsidiaries, engages in the design, manufacture, marketing, and sale of leisure vehicles for individuals and professionals in Europe. It offers camping cars, caravans, motorhomes, trailers, and outdoor habitats. The company also provides mobiles homes, spare parts, and accessories, as well as leisure financing services. It offers its products through dealer networks and distributors, as well as through its online sales site, Triganostore.com. Trigano S.A. was founded in 1935 and is based in Paris, France.

Earnings Per Share

As for profitability, TRIGANO has a trailing twelve months EPS of €15.95.

PE Ratio

TRIGANO has a trailing twelve months price to earnings ratio of 9.07. Meaning, the purchaser of the share is investing €9.07 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 19.15%.

Moving Average

TRIGANO’s value is way above its 50-day moving average of €126.99 and way above its 200-day moving average of €127.06.

Volatility

TRIGANO’s last week, last month’s, and last quarter’s current intraday variation average was 1.24%, 0.38%, and 1.65%.

TRIGANO’s highest amplitude of average volatility was 1.24% (last week), 1.14% (last month), and 1.65% (last quarter).

More news about TRIGANO.

9. CAMBODGE NOM. (CBDG.PA)

2.75% Foward Dividend Yield

CAMBODGE NOM.’s last close was €6,550.00, 5.07% below its 52-week high of €6,900.00. Intraday change was 0%.

Compagnie du Cambodge, together with its subsidiaries, provides transportation and logistics services in France. It operates a railway concession linking Burkina Faso with Ivory Coast. The company was incorporated in 1998 and is headquartered in Puteaux, France. Compagnie du Cambodge is a subsidiary of Plantations Des Terres Rouges S.A.

Earnings Per Share

As for profitability, CAMBODGE NOM. has a trailing twelve months EPS of €36.68.

PE Ratio

CAMBODGE NOM. has a trailing twelve months price to earnings ratio of 178.57. Meaning, the purchaser of the share is investing €178.57 for every euro of annual earnings.

Return on Equity

The company’s return on equity, which measures the profitability of a business relative to shareholder’s equity, for the twelve trailing months is 0.52%.

More news about CAMBODGE NOM..

Leave a Reply

Your email address will not be published. Required fields are marked *